New Delhi: The Indian government has decided not to extend its deadline for pharmaceutical companies to upgrade manufacturing plants to meet World Health Organization (WHO) quality standards, following a tragic cough syrup contamination that claimed the lives of at least 24 children.

The move comes in the wake of widespread outrage and global concern after several batches of cough syrups, including Coldrif manufactured by Sresan Pharmaceuticals in Tamil Nadu, were found to contain dangerously high levels of diethylene glycol (DEG), a toxic industrial chemical often used as a cheaper alternative to pharmaceutical-grade solvents.

Authorities have confirmed that the contaminated syrup led to multiple child deaths in recent weeks, mostly from acute kidney failure. Investigations revealed t

See Full Page